Tesamorelin

Description

Tesamorelin is a synthetic growth hormone-releasing factor (GHRF) analog composed of 44 amino acids. It is studied in research involving:

• Endocrine signaling
• Metabolic pathways
• Peptide-mediated cellular activity

It is investigated in laboratory settings for its interaction with:

• Pituitary growth hormone release
• Downstream insulin-like growth factor-1 (IGF-1) expression

In vitro and preclinical research explores its role in:

• Lipid metabolism models
• Anabolic signaling pathways
• Endocrine regulation

Its structural similarity to naturally occurring GHRH supports research into:

• Hormone-driven cellular processes
• Metabolic response mechanisms

Each vial contains 10mg of lyophilized Tesamorelin for laboratory research applications.

Product Specifications

• Unit Size: 10mg (lyophilized powder, single vial)
• Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
• Molecular Weight: ~5135.9 Da
• Form: Lyophilized powder

Storage Instructions

Store lyophilized peptide at 2°C–8°C in a cool, dark place. After reconstitution:

• Keep refrigerated at 2°C–8°C
• Use within an appropriate research period

Application Context (Research Use)

• Growth hormone-releasing pathway studies
• IGF-1 related signaling activity
• Endocrine and metabolic regulation models
• Lipid metabolism and adipocyte response research
• Cellular signaling related to anabolic and hormonal processes
• Peptide-receptor interaction studies

Intended Use

Intended exclusively for in vitro research use. Not approved for:

• Human use
• Animal use
• Food, drug, cosmetic, or diagnostic applications

Terms of Sale

Buyer confirms they are a qualified researcher or institution. Full responsibility for:

• Proper handling
• Storage
• Compliance with applicable laws and regulations